NECLIFENSENectar Lifesciences Limited· PharmaceuticalsHighPositive
Announced Tue, 27 Jan, 2026 · 16:38 IST

Promoter holding crosses 50% in Nectar Lifesciences after buyback

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.4%Reaction day
₹14.00
prior close
₹14.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+2.0%-2.4% vs market

On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
+0.4
15m
+0.7
30m
+1.1
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
-0.4+2.0-2.4
Next day
-1.6+1.6-3.2
2d
-3.1+3.5-6.5
3d
-0.4+2.2-2.6
4d
-0.7+6.0-6.7
5d
-1.9+7.4-9.2
1w
-3.6+5.5-9.0
15d
-5.9+7.1-13.0
1m
-16.9+1.3-18.2
2m
-33.6-8.1-25.5
3m
-9.9+12.1-22.0
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoters of Nectar Lifesciences filed disclosure under SEBI Takeover Regulations. No shares were bought or sold. The company's buyback (Dec 31, 2025 to Jan 6, 2026) extinguished 3 crore shares on Jan 20, 2026, reducing total outstanding shares. Promoter holding automatically rose from 44.91% to 51.84%, crossing the 50% threshold. Exemption claimed under Regulation 10(4)(c).

Likely market impact

Promoter holding crosses 50% without buying shares, giving majority control. Buyback benefited them automatically. Watch related party deals.